CAS: 918639-08-4 - Bosutinib monohydrate
Fórmula:C26H29Cl2N5O3.H2O
InChI:InChI=1S/C26H29Cl2N5O3.H2O/c1-32-6-8-33(9-7-32)5-4-10-36-25-13-21-18(11-24(25)35-3)26(17(15-29)16-30-21)31-22-14-23(34-2)20(28)12-19(22)27;/h11-14,16H,4-10H2,1-3H3,(H,30,31);1H2
Clave InChI:InChIKey=BXPOSPOKHGNMEP-UHFFFAOYSA-N
SMILES:N#CC1=CN=C2C=C(OCCCN3CCN(C)CC3)C(OC)=CC2=C1NC4=CC(OC)=C(Cl)C=C4Cl.O
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Bosutinib REF: 4Z-B-641CAS: | - - - | A consultar | Lun 13 May 24 |
 | Bosutinib hydrate REF: TM-T63875CAS: 918639-08-4 | 99.87% | 39,00 €~307,00 € | Lun 13 May 24 |
| Bosutinib Impurity 14 REF: 4Z-B-6418CAS: | - - - | A consultar | Vie 17 May 24 |
 | Bosutinib monohydrate REF: 3D-FB145112CAS: 918639-08-4 | Min. 95% | A consultar | Vie 21 Jun 24 |
Ref: 4Z-B-641
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 13 de Mayo de 2024
Bosutinib hydrate
CAS:918639-08-4
Bosutinib hydrate (SKI-606 hydrate) is an orally active and potent dual kinase inhibitor of BCR-ABL …
Fórmula:
C26H31Cl2N5O4
Pureza:
99.87%
Forma y color:
Solid
Peso molecular:
548.46
Ref: TM-T63875
| 5mg | 39,00 € | |
| 10mg | 58,00 € | |
| 25mg | 86,00 € | |
| 50mg | 105,00 € | |
| 100mg | 157,00 € | |
| 500mg | 307,00 € |
Entrega estimada en Estados Unidos, el Lunes 13 de Mayo de 2024
Ref: 4Z-B-6418
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 17 de Mayo de 2024
Bosutinib monohydrate
CAS:918639-08-4
Inhibitor of Abl and Src kinases; anti-proliferative; antineoplasticÂ
Fórmula:
C26H29Cl2N5O3·H2O
Pureza:
Min. 95%
Forma y color:
Slightly Yellow Powder
Peso molecular:
548.46 g/mol
Ref: 3D-FB145112
| 1g | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar | |
| 250mg | A consultar | |
| 500mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 21 de Junio de 2024
